1. Luxembourg Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Moolec Science S.A.

Moolec Science S.A.

MLEC
Moolec Science S.A.US flagNASDAQ Global Market
6.83
USD
-0.02
- -
4.96MMarket Cap

Total Valuation

Moolec Science S.A. carries a market capitalization of 5.88M, placing it among publicly traded companies globally. Its enterprise value stands at 50.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.88M
Enterprise Value50.48M

Share Statistics

Moolec Science S.A. currently has 266,691.00 shares outstanding.

Shares Outstanding266,691.00
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 3.87, and the price-to-book ratio stands at -0.43.

PE RatioN/A
PS Ratio3.87
PB Ratio-0.43
P/TBV Ratio-4.64
P/FCF Ratio-4.40
P/OCF Ratio-4.36

Enterprise Valuation

EV / Sales6.44
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Moolec Science S.A. maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 789.74, indicating elevated leverage, while an interest coverage ratio of -3.93 demonstrates limited ability to service its debt obligations.

Current Ratio1.48
Quick Ratio0.72
Debt / Equity789.74
Debt / EBITDA-2.58
Interest Coverage-3.93

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-31.42
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.17

Taxes

Income Tax-342,804.00
Effective Tax RateN/A

Stock Price Statistics

Moolec Science S.A.'s stock has declined approximately -93.6019% over the past 52 weeks. The 50-day moving average sits at 7.99, while the 200-day moving average is 10.29.

Beta (5Y)N/A
52-Week Price Change-93.6019%
50-Day Moving Average7.99
200-Day Moving Average10.29
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Moolec Science S.A. generated 7.83M in revenue and converted that into -8.28M in net income, yielding earnings per share of -32.77. EBITDA reached -8.57M, while operating income came in at -9.14M.

Revenue7.83M
Gross Profit-639,496.00
Operating Income-9.14M
Pretax Income-8.62M
Net Income-8.28M
EBITDA-8.57M
EBIT-9.14M
Earnings Per Share (EPS)-32.77

Balance Sheet

Moolec Science S.A. holds 1.93M in cash and equivalents against 22.09M in total debt, resulting in a net debt position of 19.81M. Total book value stands at -69.88M, with working capital of 3.09M providing operational flexibility.

Cash & Cash Equivalents1.93M
Total Debt22.09M
Net Debt19.81M
Equity (Book Value)-69.88M
Book Value Per Share-276.50
Working Capital3.09M

Cash Flow

Moolec Science S.A. produced -6.96M in operating cash flow over the past twelve months. After subtracting -61,362.00 in capital expenditures, free cash flow totaled -7.02M - equivalent to -27.79 per share.

Operating Cash Flow-6.96M
Capital Expenditures-61,362.00
Free Cash Flow-7.02M
FCF Per Share-27.79

Margins

Moolec Science S.A. operates with a gross margin of -8.16, reflecting its pricing power and cost economics. The operating margin of -116.72 and net profit margin of -105.71 provide insight into operational efficiency.

Gross Margin-8.16
Operating Margin-116.72
Pretax Margin-110.09
Profit Margin-105.71
EBITDA Margin-109.41

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield6.07
FCF Yield-22.75

Stock Splits

Moolec Science S.A.'s most recent stock split took place on January 5, 2026 with a 15:1 split ratio.

Last Split Date1/5/2026
Split Ratio15:1

Scores

Moolec Science S.A. posts an Altman Z-Score of -4.67, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-4.67